Global Antiinfective Medicine Sales by Country

The global antiinfective medicine sales data for 2024, measured in billions of U.S. dollars, shows Italy in the lead with 2.74 billion, followed by Spain at 1.96 billion and Croatia close behind at 1.92 billion. Year-on-year variations reveal an interesting spectrum of market dynamics: Italy saw a decline of 4.51%, while Spain's market contracted by 1.93%, and Croatia experienced a significant surge at 21.52%. Notable declines include Sweden at 5.59% and New Zealand at 7.47%. In contrast, Iceland (6.72%) and Luxembourg (8.75%) exhibited substantial growth. Over a five-year period, the average annual growth rate (CAGR) offers a more stable perspective on market trends.

Future trends to watch in the global antiinfective medicine sales landscape include the potential impact of emerging resistance to antibiotics, shifts in regulatory policies, and innovation in pharmaceutical technologies. Markets to particularly keep an eye on include Croatia, Iceland, and Luxembourg, all of which have shown promising growth trajectories despite broader market fluctuations.